Cargando…

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer

SIMPLE SUMMARY: Currently, there is no effective treatment that can cure metastatic prostate cancer. Various pros-tate specific membrane antigen (PSMA)-targeted radioimaging and radiotherapy agents have en-tered clinical trials; however, no PSMA-targeted chemotherapy is currently in clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinning, Shirke, Aditi, Walker, Ethan, Sun, Rongcan, Ramamurthy, Gopolakrishnan, Wang, Jing, Shan, Lingpeng, Mangadlao, Joey, Dong, Zhipeng, Li, Jing, Wang, Ziying, Schluchter, Mark, Luo, Dong, Wang, Yu, Stauffer, Shaun, Brady-Kalnay, Susann, Hoimes, Christopher, Lee, Zhenghong, Basilion, James P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865627/ https://www.ncbi.nlm.nih.gov/pubmed/33499427 http://dx.doi.org/10.3390/cancers13030417

Ejemplares similares

A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer
por: Wang, Xinning, et al.
Publicado: (2022)

Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?
por: Luo, Dong, et al.
Publicado: (2019)

Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021)

GCP III is not the “off-target” for urea-based PSMA ligands
por: Lee, Zhenghong, et al.
Publicado: (2023)

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers
por: Wang, Xinning, et al.
Publicado: (2021)

Ultrasound-mediated drug-free theranostics for treatment of prostate cancer
por: Perera, Reshani Himashika, et al.
Publicado: (2023)

Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis
por: Luo, Dong, et al.
Publicado: (2021)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
por: Wang, Cong, et al.
Publicado: (2019)

Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin
por: Zhou, Jie, et al.
Publicado: (2020)

Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents
por: Johansen, Mette L., et al.
Publicado: (2021)

Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitro
por: Perera, Reshani H., et al.
Publicado: (2022)

Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
por: Martin, Stacy E., et al.
Publicado: (2014)

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
por: Gonzalez, Paulina, et al.
Publicado: (2023)

Dynamic Quantitative T1 Mapping in Orthotopic Brain Tumor Xenografts()
por: Herrmann, Kelsey, et al.
Publicado: (2016)

Identification of oxidized protein hydrolase as a potential prodrug target in prostate cancer
por: McGoldrick, Christopher A, et al.
Publicado: (2014)

Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue
por: Cutter, Jennifer L., et al.
Publicado: (2012)

Novel therapies are changing treatment paradigms in metastatic prostate cancer
por: Powers, Eric, et al.
Publicado: (2020)

The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer
por: Chuang, C-H, et al.
Publicado: (2014)

The pH dependent reactions of graphene oxide with small molecule thiols
por: de Leon, Al, et al.
Publicado: (2018)

A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy
por: Wang, Yifan, et al.
Publicado: (2019)

In Vivo Imaging of Schistosomes to Assess Disease Burden Using Positron Emission Tomography (PET)
por: Salem, Nicolas, et al.
Publicado: (2010)

In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells
por: McGoldrick, Christopher A, et al.
Publicado: (2014)

Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System
por: Qu, Zhen, et al.
Publicado: (2021)

Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
por: Huang, Gang, et al.
Publicado: (2022)

A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
por: Boinapally, Srikanth, et al.
Publicado: (2021)

Oligo(Lactic Acid)(8)-Docetaxel Prodrug-Loaded PEG-b-PLA Micelles for Prostate Cancer
por: Repp, Lauren, et al.
Publicado: (2021)

Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer
por: Wang, Fangming, et al.
Publicado: (2022)

Voltage-gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells
por: SHAN, BIN, et al.
Publicado: (2014)

PTPμ Regulates N-Cadherin–dependent Neurite Outgrowth
por: Burden-Gulley, Susan M., et al.
Publicado: (1999)

Artificial Intelligence-Based Computational Screening and Functional Assays Identify Candidate Small Molecule Antagonists of PTPmu-Dependent Adhesion
por: Molyneaux, Kathleen, et al.
Publicado: (2023)

A novel binding pocket in the D2 domain of protein tyrosine phosphatase mu (PTPmu) guides AI screen to identify small molecules that modulate tumour cell adhesion, growth and migration
por: Molyneaux, Kathleen, et al.
Publicado: (2023)

Identifying the role of apolipoprotein A-I in prostate cancer
por: Wang, Jing, et al.
Publicado: (2021)

Survival outcomes of low prostate-specific antigen levels and T stages in patients with high-grade prostate cancer: a population-matched study
por: Kang, Yongming, et al.
Publicado: (2020)

Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells
por: Meng, Ping, et al.
Publicado: (2017)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
por: Zhang, Jin Long, et al.
Publicado: (2018)

Integrative Epigenome Map of the Normal Human Prostate Provides Insights Into Prostate Cancer Predisposition
por: Wang, Tao, et al.
Publicado: (2021)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

Effects of substrate stiffness on the viscoelasticity and migration of prostate cancer cells examined by atomic force microscopy
por: Tang, Xiaoqiong, et al.
Publicado: (2022)

Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy
por: Wang, Weiwei, et al.
Publicado: (2020)

Identification of Ferroptosis-Associated Genes in Prostate Cancer by Bioinformatics Analysis
por: Wo, Qijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3u0aais2cfm3vprrdhee2s4kt